{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:24:14Z","timestamp":1791044654273,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.neuro.2007.02.004","type":"journal-article","created":{"date-parts":[[2007,2,12]],"date-time":"2007-02-12T06:57:48Z","timestamp":1171263468000},"page":"445-449","source":"Crossref","is-referenced-by-count":75,"title":["Stoichiometry and conditional stability constants of Cu(II) or Zn(II) clioquinol complexes; implications for Alzheimer's and Huntington's disease therapy"],"prefix":"10.1016","volume":"28","author":[{"given":"Evandro","family":"Ferrada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Arancibia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara","family":"Loeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Norambuena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Olea-Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Pablo","family":"Huidobro-Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2007.02.004_bib1","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1046\/j.1471-4159.2000.0741529.x","article-title":"Zinc and copper modulate differentially the P2X4 receptor","volume":"74","author":"Acu\u00f1a-Castillo","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2007.02.004_bib2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ddr.10083","article-title":"Metal ion chelation in neurodegenerative disorders","volume":"56","author":"Angel","year":"2002","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.neuro.2007.02.004_bib3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0197-4580(02)00120-3","article-title":"Metal complexing agents as therapies for Alzheimer's disease","volume":"23","author":"Bush","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2007.02.004_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0166-2236(03)00067-5","article-title":"The metallobiology of Alzheimer's disease","volume":"4","author":"Bush","year":"2003","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuro.2007.02.004_bib5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.0022-3042.2001.00732.x","article-title":"Formation of carnosine-Cu(II) complexes prevents and reverts the inhibitory action of copper in P2X4 and P2X7 receptors","volume":"80","author":"Coddou","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2007.02.004_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0304-4203(99)00054-7","article-title":"Polarographic determination of half-wave potentials for copper organic complexes in sea water","volume":"67","author":"Croot","year":"1999","journal-title":"Mar Chem"},{"key":"10.1016\/j.neuro.2007.02.004_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0009-2614(01)01173-3","article-title":"Excited-state dynamics in 8-hydroxyquinoline dimers","volume":"349","author":"Cheatum","year":"2001","journal-title":"Chem Phys Lett"},{"key":"10.1016\/j.neuro.2007.02.004_bib8","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1021\/ic0494051","article-title":"Clioquinol a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes","volume":"43","author":"Di Vaira","year":"2004","journal-title":"Inorg Chem"},{"key":"10.1016\/j.neuro.2007.02.004_bib9","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1021\/ja01141a001","article-title":"Structure and behavior of organic analytical reagents. III. Stability of chelates of 8-hydroxyquinoline and analogous reagents","volume":"74","author":"Johnston","year":"1952","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.neuro.2007.02.004_bib10","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1021\/ja01502a006","article-title":"Chelate stabilities of certain oxine-type compounds","volume":"82","author":"Lane","year":"1960","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.neuro.2007.02.004_bib11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1471-4159.2003.01705.x","article-title":"The human prion octarepeat fragment prevents and reverses the inhibitory action of copper in the P2X4 receptor without modifying the zinc action","volume":"85","author":"Lorca","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2007.02.004_bib12","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1039\/a707858g","article-title":"Synthesis, crystal structure, molecular orbital calculations and electronic properties of 2,3-di(2-pyridyl)naphtho[2,3-f]quinoxaline-7,12-quinone (Aqdpp)","volume":"2","author":"L\u00f3pez","year":"1998","journal-title":"J Chem Soc Perkin Trans"},{"key":"10.1016\/j.neuro.2007.02.004_bib13","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down Syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuro.2007.02.004_bib14","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1073\/pnas.0502177102","article-title":"Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model","volume":"102","author":"Nguyen","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuro.2007.02.004_bib15","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","article-title":"Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A\u03b2 amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial","volume":"60","author":"Ritchie","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuro.2007.02.004_bib16","series-title":"Instrumental analysis","author":"Skoog","year":"1994"},{"key":"10.1016\/j.neuro.2007.02.004_bib17","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1073\/pnas.93.8.3684","article-title":"P2X4: an ATP-activated ionotropic receptor cloned from rat brain","volume":"93","author":"Soto","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuro.2007.02.004_bib18","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1126\/science.292.5525.2251","article-title":"Clioquinol's return: cautions from Japan","volume":"292","author":"Takeshi","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuro.2007.02.004_bib19","doi-asserted-by":"crossref","first-page":"51958","DOI":"10.1074\/jbc.M407410200","article-title":"Clioquinol mediates copper uptake and counteracts copper efflux activities of the amyloid precursor protein of Alzheimer's disease","volume":"279","author":"Treiber","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2007.02.004_bib20","doi-asserted-by":"crossref","first-page":"C271","DOI":"10.1152\/ajpcell.00160.2005","article-title":"Induction of cellular prion protein gene expression by copper in neurons Am","volume":"290","author":"Varela-Nallar","year":"2005","journal-title":"J Physiol Cell Physiol"},{"key":"10.1016\/j.neuro.2007.02.004_bib21","doi-asserted-by":"crossref","first-page":"17670","DOI":"10.1074\/jbc.M602487200","article-title":"Degradation of the alzheimer's disease amyloid beta peptide by metal-dependent up-regulation of metalloprotease activity","volume":"281","author":"White","year":"2006","journal-title":"J Biol Chem"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X07000393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X07000393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T04:22:33Z","timestamp":1547007753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X07000393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0161813X07000393"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2007.02.004","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}